Duchenne muscular dystrophy: case series of rare inherited muscular disorder
Keywords:DMD, Dystrophinopathies, Inherited disorder
Duchenne muscular dystrophy (DMD) is a rare muscular disorder caused by mutation of gene encoding dystrophin protein which required for maintaining muscle stability during contraction. DMD occurs in 1 in 5000 male live births and characterized by progressive muscular weakness associated with motor development delay, loss of independent ambulation, respiratory failure, and cardiomyopathy. We present a case series of 3 DMD patients who were diagnosed at Prof. dr. I.G.N.G. Ngoerah general hospital, Denpasar over a period of four years (2019-2022). Clinical manifestation of patients includes progressive weakness of lower extremities and difficulty to stand up from sitting position. Physical examination revealed pseudohypertrophy of calf, winged scapula, positive Gower’s sign, and waddling gait in all three cases. Supporting examination showed an increase of alanine transaminase and aspartate transaminase 5.6 times and 6.1 times the upper limit of normal, respectively. Definitive diagnosis of all patient was made based on immunohistochemistry staining which revealed an absent of dystrophin protein around muscle membrane.
Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for duchenne muscular dystrophy. J Med Genet. 2016;53:145-51.
Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio P, Scutifero M et al. Improvement of survival in duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myol. 2012;31(2):121-5.
Sinha R, Sarkar S, Khaitan T, Dutta S. Duchenne muscular dystrophy: case report and review. J Family Med Prim Care. 2017;6:654-6.
Rahmawati PL, Wijayanti IAS, Arimbawa IK, Purwata TE, Putra IGNP, Sumadi IWJ et al. Serial case report: becker’s muscular dystrophy phenotype with dilated cardiomyopathy in patients with out-of-frame deletion involving exons 38-43 of DMD gene. Neurology Asia. 2021;26(1):153-9.
Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13.
Tsuda T. Clinical manifestations and overall management strategies for duchenne muscular dystrophy. Methods Mol Biol. 2018;1687:19-28.
Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifiro G. Global epidemiology of duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15:141.
Venugopal V, Pavlakis S. Duchenne muscular dystrophy. Treasure Island: StatPearls Publishing. 2022.
McMillan HJ, Gregas M, Darras BT, Kang PB. Serum transaminase levels in boys with Duchenne and becker muscular dystrophy. Pediatrics. 2011;127(1):e132-6.
Zhu Y, Zhang H, Sun Y, Li Y, Deng L, Wen X et al. Serum enzyme profiles differentiate five types of muscular dystrophy. Dis Markers. 2015;2015:543282.
Paganoni S, Amato A. Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin N Am, 2013;24(1):193-207.